Bessemer Group
COLL icon

Bessemer Group’s Collegium Pharmaceutical COLL Stock Holding History

Bessemer Group’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.55M Sell
98,014
-6
-0% -$205 ﹤0.01% 698
2026
Q1 		$3.24M Buy
98,020
+31,800
+48% +$1.35M 0.01% 654
2025
Q4 		$3.07M Buy
66,220
+65,977
+27,151% +$2.76M ﹤0.01% 687
2025
Q3 		$9K Buy
243
+103
+74% +$3.58K ﹤0.01% 1976
2025
Q2 		$4K Sell
140
-9
-6% -$257 ﹤0.01% 2061
2025
Q1 		$4K Sell
149
-4
-3% -$122 ﹤0.01% 2075
2024
Q4 		$5K Hold
153
– – ﹤0.01% 1989
2024
Q3 		$6K Buy
153
+33
+28% +$1.18K ﹤0.01% 1839
2024
Q2 		$4K Hold
120
– – ﹤0.01% 1739
2024
Q1 		$5K Buy
+120
New +$4.2K ﹤0.01% 1696
2023
Q1 		– Sell
-215
Closed -$5K – 1935
2022
Q4 		$5K Hold
215
– – ﹤0.01% 1553
2022
Q3 		$3K Sell
215
-16
-7% -$282 ﹤0.01% 1831
2022
Q2 		$4K Sell
231
-269
-54% -$4.53K ﹤0.01% 1574
2022
Q1 		$10K Buy
500
+18
+4% +$340 ﹤0.01% 1378
2021
Q4 		$9K Buy
482
+213
+79% +$4.15K ﹤0.01% 1438
2021
Q3 		$5K Hold
269
– – ﹤0.01% 1502
2021
Q2 		$6K Hold
269
– – ﹤0.01% 1404
2021
Q1 		$6K Buy
+269
New +$6.39K ﹤0.01% 1368
2020
Q3 		– Sell
-12,200
Closed -$214K – 1407
2020
Q2 		$214K Hold
12,200
– – ﹤0.01% 1136
2020
Q1 		$199K Buy
+12,200
New +$252K ﹤0.01% 998
2019
Q4 		– Sell
-53,300
Closed -$612K – 1651
2019
Q3 		$612K Buy
+53,300
New +$608K ﹤0.01% 828
2019
Q2 		– Sell
-32,300
Closed -$489K – 1662
2019
Q1 		$489K Hold
32,300
– – ﹤0.01% 800
2018
Q4 		$555K Buy
+32,300
New +$553K ﹤0.01% 718

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Bessemer Group's COLL Position: Q2 2026 in Review

Bessemer Group reduced its Collegium Pharmaceutical (COLL) stake by 0.01% in Q2 2026, selling an estimated $205 and leaving 98,014 shares worth $3.55M. The position accounts for ﹤0.01% of the portfolio, ranked #698.

Bessemer Group first reported a position in COLL in Q4 2018 and has held it in 23 quarters since. 279 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • Bessemer Group held 98,014 shares of Collegium Pharmaceutical worth $3.55M as of Q2 2026.
  • Bessemer Group sold 6 Collegium Pharmaceutical shares in Q2 2026, an estimated $205.
  • Collegium Pharmaceutical made up ﹤0.01% of Bessemer Group's portfolio in Q2 2026, its #698 holding.
  • Bessemer Group first reported a position in Collegium Pharmaceutical in Q4 2018 and has held it in 23 quarters since.
  • 279 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Bessemer Group's 13F filing for Q2 2026, filed 12 Aug 2026.